Revenue Growth
Q1 2026 revenue was $26.9 million (versus $23.0M in the most recent comparative period and $19.4M in the year-ago period), implying roughly +17% sequential and +39% year-over-year increases.
Indium Phosphide Strength & Mix
Indium phosphide revenue was $13.6 million, representing just north of 50% of total Q1 revenue and driving much of the margin and revenue expansion; indium phosphide backlog exceeded $100 million.
Margin Expansion
Non-GAAP gross margin improved to 29.9% (GAAP gross margin 29.6%), up from 21.5% (non-GAAP) and a negative gross margin in the prior-year period (non-GAAP -6.1%), a multi-decade-style swing in profitability.
Narrowing Losses and Path to Profitability
Non-GAAP operating loss narrowed to $0.55M (from $2.6M prior period and ~$9.6M year-ago); non-GAAP net loss was $0.585M ($0.01/share) versus $2.3M prior quarter and $8.2M year-ago. Company expects GAAP and non-GAAP profitability in Q2 with non-GAAP EPS $0.06–$0.08 and GAAP EPS $0.05–$0.07.
Substantial Capital Raise
Completed a $632.5 million capital raise to support Tongmei indium phosphide capacity expansion, R&D (including 6-inch IP), and working capital.
Aggressive Capacity Expansion Plan
Company is ahead of plan to double indium phosphide capacity in 2026, targeting ~ $35M per quarter capacity by end of 2026 and ~ $65–$70M per quarter by 2027 (annualized exit rates cited of ~$140M then ~$280M).
Raw Materials & Vertical Integration
Subsidiary Jinmei began refining high-purity indium, strengthening control of critical raw materials and supporting guaranteed supply for indium phosphide substrates—positioned as a competitive differentiator.
Geographic & Customer Momentum
Asia Pacific comprised 78% of revenue in Q1; top five customers ~32% of revenue with no single customer >10%; management reports expanding relationships with tier-one customers and hyperscalers, and increased customer visibility and long-term supply discussions.